2015-06 | Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models | Son, Hyo Jin; Choi, Ji Hyun; Lee, Ji Ae; Kim, Dong Jin; Shin, Kye Jung; Hwang, Onyou |
2019-10 | KMS99220 Exerts Anti-Inflammatory Effects, Activates the Nrf2 Signaling and Interferes with IKK, JNK and p38 MAPK via HO-1 | Lee, Ji Ae; Kim, Dong Jin; Hwang, Onyou |
2014-05 | Optogenetic Inactivation of the Subthalamic Nucleus Improves Forelimb Akinesia in a Rat Model of Parkinson Disease | Yoon, Hyung Ho; Park, Jin Hoon; Kim, Yong Hwan; Min, Joongkee; Hwang, Eunmi; Lee, C. Justin; Suh, Jun-Kyo Francis; Hwang, Onyou; Jeon, Sang Ryong |
2016-05 | Optogenetic Inhibition of the Subthalamic Nucleus Reduces Levodopa-Induced Dyskinesias in a Rat Model of Parkinson's Disease | Yoon, Hyung Ho; Min, Joongkee; Hwang, Eunmi; Lee, C. Justin; Suh, Jun-Kyo Francis; Hwang, Onyou; Jeon, Sang Ryong |
2018-10 | The Novel Neuroprotective Compound KMS99220 Has an Early Anti-neuroinflammatory Effect via AMPK and HO-1, Independent of Nrf2 | Lee, Ji Ae; Kim, Hye Ri; Kim, Jiyoung; Park, Ki Duk; Kim, Dong Jin; Hwang, Onyou |